Drug recall · August 7, 2024
Ciprofloxacin ophthalmic solution USP recall
Why: Defective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ciprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5 mL (NDC 69315-308-02), Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India.
- Lots / codes
Lot#: a) 084C040, Exp 02/28/2026; b) 084A024, Exp12/31/2025.
- Quantity
- 66,528 bottles
- Company
- FDC Limited, Aurangabad, Maharashtra State, N/A
- Distribution
- U.S. A. Nationwide
- Initiated
- July 23, 2024 · Voluntary: Firm initiated
- Classified
- August 1, 2024
- Reported
- August 7, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ciprofloxacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.